A Phase I Study of SNH-119014 in Healthy Volunteers

NCT07087262 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

96

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemoglobinopathy

Interventions

DRUG: SNH-119014
DRUG: Placebo

Sponsor

ScinnoHub Pharmaceutical Co., Ltd.